跳至主要内容
临床试验/ISRCTN56900576
ISRCTN56900576已完成未知

Functional magnetic resonance lung imaging using inhaled hyperpolarised 129xenon in healthy volunteers and patients with chronic obstructive pulmonary disease

niversity of Nottingham0 个研究点目标入组 53 人开始时间: 2015年11月17日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
发起方
入组人数
53

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

性别
All

入选标准

  • Current participant inclusion criteria as of 22/12/2022:
  • General inclusion criteria:
  • 1. Aged 18 years or over
  • 2. Capacity to give informed consent
  • 3. Normal blood pressure (systolic BP > 100 mmHg and diastolic BP > 70 mmHg)
  • 4. Resting heart rate > 50 bpm
  • 5. For women, negative urinary ß-hCG at the screening and subsequent visits
  • 6. Subject able to hold breath for 10 seconds
  • 7. Subject able to fit into 129Xe chest coil used for MRI
  • 8. Subject able to understand the requirements of the study and to cooperate with the study procedures
  • Healthy volunteer inclusion criteria:
  • No significant respiratory disease within the last year
  • COPD patient inclusion criteria:
  • 1. Evidence of airflow obstruction (FEV/FVC <0.7) and FEV1 <80% predicted post bronchodilator
  • 2. Minimum FVC 1.5L
  • Previous participant inclusion criteria:
  • General inclusion criteria:
  • 1. Aged 18 years or over
  • 2. Capacity to give informed consent
  • 3. Normal blood pressure (systolic BP > 100 mmHg and diastolic BP > 70 mmHg)
  • 4. Resting heart rate > 50 bpm
  • 5. For women, negative urinary ß-hCG at the screening and subsequent visits
  • 6. Subject able to hold breath for 10 seconds
  • 7. Subject able to fit into 129Xe chest coil used for MRI
  • 8. Subject able to understand the requirements of the study and to cooperate with the study procedures
  • Healthy volunteer inclusion criteria:
  • No significant respiratory disease within the last year
  • COPD patient inclusion criteria:
  • 1. Evidence of airflow obstruction (FEV/FVC <0.7) and FEV1 <80% predicted post bronchodilator
  • 2. Minimum FVC 1.5L
  • IPF patient inclusion criteria:
  • 1. Diagnosis of IPF by high resolution CT scan
  • 2. Full pulmonary function test performed within 12 months prior to imaging
  • 3. Minimum FVC 1.5

排除标准

  • Healthy volunteer exclusion criteria:
  • 1. Unsuitable for MRI scanning (e.g. have metal implants or pacemaker or contraindicated following questionnaire)
  • 2. Acute respiratory illness within 30 days of MRI
  • 3. Subject has received an IMP (not including hyperpolarized 129Xe) within 30 days of MRI and administration of 129Xe deemed inappropriate in context of other study
  • 4. Subject deemed unlikely to comply with instructions during imaging
  • 5. Do not meet the inclusion criteria above
  • 6. Subject not deemed fit enough to tolerate procedure
  • 7. Subject deemed unsuitable by clinical investigator for other reasons
  • COPD and IPD patient exclusion criteria:
  • 1. Unsuitable for MRI scanning (e.g. have metal implants or pacemaker or contraindicated following questionnaire)
  • 2. Acute respiratory illness within 30 days of MRI
  • 3. Subject has received an IMP (not including hyperpolarized 129Xe) within 30 days of MRI and administration of 129Xe deemed inappropriate in context of other study
  • 4. Subject deemed unlikely to comply with instructions during imaging
  • 5. Do not meet the inclusion criteria above
  • 6. Subject not deemed fit enough to tolerate procedure
  • 7. Subject deemed unsuitable by clinical investigator for other reasons

研究者

发起方
niversity of Nottingham

相似试验

Functional magnetic resonance lung imaging using... | 临床试验